A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.

Ilies Benotmane Aurélie Velay Gabriela-Gautier Vargas Jérôme Olagne Noëlle Cognard Françoise Heibel Laura Braun-Parvez Jonas Martzloff Peggy Perrin Romain Pszczolinski Bruno Moulin Samira Fafi-Kremer Sophie Caillard

Kidney Int

Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital, Strasbourg, France; Unité mixte de recherche (UMR) S1109 Labex Transplantex, Institut national de la santé et de la recherche médicale (Inserm) Fédération de Médecine Translationnelle, Strasbourg University, Strasbourg France.

Published: November 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375643	PMC
http://dx.doi.org/10.1016/j.kint.2022.07.022	DOI Listing

Publication Analysis

Top Keywords

rapid decline

decline anti-receptor-binding

anti-receptor-binding domain

domain sars-cov-2

sars-cov-2 spike

spike protein

protein igg

igg titer

titer kidney

kidney transplant

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!